IDPS HomeInfectious Diseases A-CD-GH-LM-QR-ST-ZHealthcare SafetyVaccine Preventable DiseasesIDPS Health TopicsImmunization UnitDisease ReportingAbout IDPSRelated DSHS SitesRelated Rules & Regulations
  • Contact Us

    TB and Hansen's Disease Branch

    MC 1939
    P.O. Box 149347
    Austin, TX 78756-9347

    Phone: 737-255-4300
    Fax: 512-989-4010

    Email the TB Program

TB Control Standards


  1. TB Program Requirements
  2. Standing Delegation Orders
  3. Policies and Procedures
  4. TXPHIN User Guide (PDF : 1,575 kB)

TB Program Requirements
Title Revised
Texas Tuberculosis Work Plan (PDF : 1,346 kB) 8/31/2020
Tuberculosis Specimen Shipping Guide (PDF : 1,679 kB)
Binational Tuberculosis (TB) Program Manual (PDF : 505 kB) 8/1/2017
Video-Enabled Directly Observed Therapy, Required and Recommended Activities (PDF : 368 kB) 8/31/2020
Terapia Directamente Observada por Video, Actividades Requeridas y Recomendaciones (PDF : 323 kB) 8/31/2020 
DSHS Tuberculosis Standards for Texas Correctional and Detention Facilities (PDF : 605 kB) 8/30/2018
Onsite TB Review Tool (PDF : 707 kB) 2/1/2020

Back to Top

Standing Delegation Orders FY 2021 
Title Revised
Tuberculosis Clinical Services Provided by Authorized Licensed Nurses (PDF : 1,048 kB) 8/31/2020
Tuberculosis Directly Observed Therapy (DOT) Services Provided by Authorized Staff (PDF : 428 kB) 8/31/2020
Tuberculosis Sputum Collection Services Provided by Authorized Staff (PDF : 390 kB) 8/31/2020
Tuberculosis Tuberculin Skin Testing (TST) Services Provided by Authorized Staff (PDF : 454 kB) 8/31/2020
Tuberculosis Blood Specimen Collection Services Provided by Authorized Staff (PDF : 400 kB) 8/31/2020

Back to Top

TB Policies and Procedures
Policy Name Revised
5003 Standing Delegation Orders and Procedures for TB Prevention and Control (PDF : 26 kB) 9/1/2013
TB-1002 Frequency of Tuberculin Skin Testing for Tuberculosis Infection for Adults in Various Settings (PDF : 60 kB) 6/26/2008
TB-1003 Tuberculosis Screening for Children in Various Settings (PDF : 214 kB)
TB-1004 Anergy Testing (PDF : 26 kB) 6/26/2008
TB-4002 Drug Resistance (PDF : 141 kB) 6/26/2008
TB-5001 Directly Observed Therapy for Active TB Disease and Latent TB Infection (PDF : 47 kB) 6/26/2008
7000 Cohort Review Policy (PDF : 46 kB) 3/9/2015
TB/HIV/STD Security Policies and Procedures

Back to Top

CDC Recommendations and Guidelines, by category

Current CDC publications for the prevention and control of TB organized by the following categories:

Control and Elimination These guidelines and recommendations address the obstacles and opportunities for controlling and eliminating TB in the United States, including the essential components of TB prevention and control programs, and the need to address TB in low-incidence areas of the United States and in communities with at-risk minority populations.
Diagnosis These diagnostic standards provide a practical guide and statement of principles for all persons involved in the care of patients with TB. They cover transmission of mycobacterium tuberculosis, clinical manifestations of TB, diagnostic microbiology, tuberculin skin test, definitions of TB disease and latent infection, and treatment of TB and TB infection.
HIV/AIDS These guidelines update previous CDC recommendations for the diagnosis, treatment, and prevention of TB among adults and children coinfected with HIV in the United States.
Infection Control Transmission of mycobacterium tuberculosis is a risk for patients and health care workers in healthcare facilities. These guidelines recommend strategies for reducing this risk in healthcare facilities.
Multidrug-Resistant TB (MDR) Outbreaks of multidrug-resistant TB (MDR) pose a public health problem and require rapid attention. These guidelines present an action plan to specifically address this problem and cover the management of persons exposed to MDR.
Testing Targeted tuberculin testing for latent tuberculosis infection (LTBI) is a strategic component of TB control that identifies persons at high risk for TB who would benefit by treatment of LTBI, if detected. These guidelines provide new recommendations for targeted tuberculin testing and treatment regimens for LTBI. Guidelines are also given to screening for TB and TB infection in high-risk populations.
Treatment These guidelines address treatment regimens for TB among adults, children, persons coinfected with HIV, persons exposed to MDR, and LTBI.
Vaccines These guidelines discuss the role of vaccines in TB prevention and control in the United States. Bacillus of Calmette and Guerin (BCG) is not recommended for programmatic use in the United States. Recognizing the importance of TB vaccines, the ACET recommends that public agencies and vaccine manufacturers develop a comprehensive strategy for new TB vaccine development.
All categories View a list of all categories for which the CDC has issued guidelines and recommendations for the prevention, treatment, and control of TB.

Back to Top

CDC TB Publications

Recommendations for Use of an Isoniazid–Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection
From CDC's MMWR Weekly; December 9, 2011 / 60(48);1650-1653

Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection — United States, 2010
From CDC's MMWR Recommendations and Reports; June 25, 2010 / 59(RR05);1-25

Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
From CDC's MMWR Weekly; January 16, 2009 / 58(01);7-10

Plan to Combat Extensively Drug-Resistant Tuberculosis
From CDC's MMWR Recommendations and Reports; February 13, 2009; 58 (RR-03); 1-43

CDC Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment (PDF)
From CDC

Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC
From CDC’s MMWR Recommendations and Reports 2006; July 7, 2006 / Vol. 55 (RR09); 1-44

Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
From CDC's MMWR Recommendations and Reports; December 16, 2005; 54(No. RR-15): 49—55.

Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis
From Centers for Disease Control and Prevention's (CDC) MMWR Recommendations and Reports: December 16, 2005 / Vol. 54(RR15): 1-37

Controlling Tuberculosis in the United States – Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America
From CDC’s MMWR: November 4, 2005 / Vol. 54(RR12): 1-81

Guidelines for Preventing the Transmission of Mycobacterium tuberculosisin Health-Care Settings, 2005
From CDC’s MMWR Recommendations and Reports
, December 30, 2005 / Vol. 54 (RR17); 1-141

Slide Set — Guidelines for Preventing the Transmission of M. tuberculosis in Health-Care Settings, 2005

Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC
From CDC’s MMWR Recommendations and Reports 2005; December 16, 2005 / Vol. 54 (RR15)/ 1-37

Treatment of Tuberculosis
American Thoracic Society, CDC, and Infectious Diseases Society of America
MMWR: June 20, 2003 / Vol. 52 (RR11): 1-77

Appendix B-Tuberculosis (TB) risk assessment worksheet )

TB Guidelines
From DTBE, a listing of all TB Guidelines issued from the division

Progressing Toward Tuberculosis Elimination in Low-Incidence Areas of the United States - Recommendations of the Advisory Council for the Elimination of Tuberculosis
From CDC’s MMWR Recommendations and Reports: May 3, 2002 / Vol. 51 (RR05);1-16

Diagnostic Standards/Classification of TB in Adults and Children (PDF)
American Journal of Respiratory Care and Critical Care Medicine, 2000; Vol. 161:1376-1395.

Back to Top

Last updated September 11, 2020